Veklury
The Latest
-
Remdesivir Use Expanded To Include Patients With Suspected COVID-19
The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19. 
The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19. -
Gilead Files New Drug Application With U.S. Regulator For Remdesivir
The European Union, Japan and Australia, among others, have already approved the use of remdesivir. 
The European Union, Japan and Australia, among others, have already approved the use of remdesivir. -
Anti-COVID-19 Drug Remdesivir Approved For Use Within EU
The European Union has granted approval for remdesivir to be used in its 27 member states to treat serious cases of COVID-19. The European Union has granted approval for remdesivir to be used in its 27 member states to treat serious cases of COVID-19. -
‘Remdesivir’ Receives Japanese Government's Approval
Remdesivir, the only approved treatment for COVID-19, will soon be available in Japan. Remdesivir, the only approved treatment for COVID-19, will soon be available in Japan.
